Literature DB >> 8785484

Glycosylation of alpha 1-acid glycoprotein in septic shock: changes in degree of branching and in expression of sialyl Lewis(x) groups.

E C Brinkman-van der Linden1, E C van Ommen, W van Dijk.   

Abstract

The occurrence of differences in acute-phase response, with respect to concentration and glycosylation of alpha 1-acid glycoprotein (AGP) was studied in the sera of patients, surviving or not from septic shock. Crossed affino-immunoelectrophoresis was used with concanavalin A and Aleuria aurantia lectin for the detection of the degree of branching and fucosylation, respectively, and the monoclonal CSLEX-1 for the detection of sialyl Lewisx (SLeX) groups on AGP. Septic shock apparently induced an acute-phase response as indicated by the increased serum levels and changed glycosylation of AGP. In the survivor group a transient increase in diantennary glycan content was accompanied by a gradually increasing fucosylation and SLeX expression, comparable to those observed in the early phase of an acute-inflammatory response. Remarkably, in the non-survivor group a modest increase in diantennary glycan content was accompanied by a strong elevation of the fucosylation of AGP and the expression of SLeX groups on AGP, typical for the late phase of an acute-phase response. Our results suggest that these changes in glycosylation of AGP can have a prognostic value for the outcome of septic shock.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8785484     DOI: 10.1007/bf01049676

Source DB:  PubMed          Journal:  Glycoconj J        ISSN: 0282-0080            Impact factor:   2.916


  23 in total

1.  Crossed immuno-affinoelectrophoresis. An analytical method to predict the result of affinity chromatography.

Authors:  T C Bog-Hansen
Journal:  Anal Biochem       Date:  1973-12       Impact factor: 3.365

2.  Immunochemical quantitation of antigens by single radial immunodiffusion.

Authors:  G Mancini; A O Carbonara; J F Heremans
Journal:  Immunochemistry       Date:  1965-09

Review 3.  Alpha 1-acid glycoprotein (orosomucoid): pathophysiological changes in glycosylation in relation to its function.

Authors:  W van Dijk; E C Havenaar; E C Brinkman-van der Linden
Journal:  Glycoconj J       Date:  1995-06       Impact factor: 2.916

4.  The use of concanavalin A crossed immuno-affinoelectrophoresis to detect hormone-associated variations in alpha 1-acid glycoprotein.

Authors:  C Wells; T C Bøg-Hansen; E H Cooper; M R Glass
Journal:  Clin Chim Acta       Date:  1981-01-08       Impact factor: 3.786

Review 5.  Mediators of septic shock: new approaches for interrupting the endogenous inflammatory cascade.

Authors:  B P Giroir
Journal:  Crit Care Med       Date:  1993-05       Impact factor: 7.598

6.  Effects of low dose methotrexate therapy on the concentration and the glycosylation of alpha 1-acid glycoprotein in the serum of patients with rheumatoid arthritis: a longitudinal study.

Authors:  T W De Graaf; E C Van Ommen; M E Van der Stelt; P J Kerstens; A M Boerbooms; W Van Dijk
Journal:  J Rheumatol       Date:  1994-12       Impact factor: 4.666

7.  Microheterogeneity of alpha 1-acid glycoprotein in the detection of intercurrent infection in systemic lupus erythematosus.

Authors:  A Mackiewicz; R Marcinkowska-Pieta; S Ballou; S Mackiewicz; I Kushner
Journal:  Arthritis Rheum       Date:  1987-05

8.  Microheterogeneity forms of alpha 1-acid glycoprotein as indicators of rheumatoid arthritis activity.

Authors:  A Mackiewicz; T Pawłowski; A Mackiewicz-Pawłowska; K Wiktorowicz; S Mackiewicz
Journal:  Clin Chim Acta       Date:  1987-03-16       Impact factor: 3.786

9.  Increased plasma levels of human interleukin for DA1.a cells/leukemia inhibitory factor in sepsis correlate with shock and poor prognosis.

Authors:  D Villers; T Dao; J M Nguyen; E Bironneau; A Godard; M Moreau; D De Groote; F Nicolas; J P Soulillou; I Anegon
Journal:  J Infect Dis       Date:  1995-01       Impact factor: 5.226

10.  Inflammation-induced expression of sialyl Lewis X-containing glycan structures on alpha 1-acid glycoprotein (orosomucoid) in human sera.

Authors:  T W De Graaf; M E Van der Stelt; M G Anbergen; W van Dijk
Journal:  J Exp Med       Date:  1993-03-01       Impact factor: 14.307

View more
  23 in total

1.  Increased alpha3-fucosylation of alpha1-acid glycoprotein in Type I diabetic patients is related to vascular function.

Authors:  D C Poland; C G Schalkwijk; C D Stehouwer; C A Koeleman; B van het Hof; W van Dijk
Journal:  Glycoconj J       Date:  2001-03       Impact factor: 2.916

2.  Natural ligands for CD33-related Siglecs?

Authors:  Ajit Varki
Journal:  Glycobiology       Date:  2009-05-09       Impact factor: 4.313

3.  Sialic acid residues play a pivotal role in alpha(1)-acid glycoprotein (AGP)-induced generation of reactive oxygen species in chemotactic peptide pre-activated neutrophil granulocytes.

Authors:  Peter Gunnarsson; Louise Fornander; Peter Påhlsson; Magnus Grenegård
Journal:  Inflamm Res       Date:  2009-08-11       Impact factor: 4.575

4.  Studies on the interaction between hyaluronan and a rat colon cancer cell line.

Authors:  C Samuelsson; S Gustafson
Journal:  Glycoconj J       Date:  1998-02       Impact factor: 2.916

5.  An improved ELISA for the determination of sialyl Lewis(x) structures on purified glycoconjugates.

Authors:  I Katnik; M T Goodarzi; G A Turner
Journal:  Glycoconj J       Date:  1996-12       Impact factor: 2.916

Review 6.  Carbohydrate composition and immunomodulatory activity of different glycoforms of alpha1-acid glycoprotein.

Authors:  S D Shiyan; N V Bovin
Journal:  Glycoconj J       Date:  1997-08       Impact factor: 2.916

7.  Acute phase proteins are major clients for the chaperone action of α₂-macroglobulin in human plasma.

Authors:  Amy R Wyatt; Nathan W Zammit; Mark R Wilson
Journal:  Cell Stress Chaperones       Date:  2012-08-16       Impact factor: 3.667

Review 8.  Sepsis biomarkers: a review.

Authors:  Charalampos Pierrakos; Jean-Louis Vincent
Journal:  Crit Care       Date:  2010-02-09       Impact factor: 9.097

9.  Severe rheumatoid arthritis prohibits the pregnancy-induced decrease in alpha3-fucosylation of alpha1-acid glycoprotein.

Authors:  E C Havenaar; J S Axford; E C Brinkman-van der Linden; A Alavi; E C Van Ommen; B van het Hof; T Spector; A Mackiewicz; W Van Dijk
Journal:  Glycoconj J       Date:  1998-07       Impact factor: 2.916

10.  Distinct glycoforms of human alpha1-acid glycoprotein have comparable synthesis rates: a [13C]valine-labelling study in healthy humans.

Authors:  Dennis C W Poland; Willem Kulik; Willem van Dijk; Marcella M Hallemeesch; Cornelis Jakobs; Kees de Meer
Journal:  Glycoconj J       Date:  2004       Impact factor: 2.916

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.